Article Information
History
- February 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Philipp E. Geyer1,*,
- Florian M. Arend2,
- Sophia Doll1,
- Marie-Luise Louiset2,
- Sebastian Virreira Winter1,
- Johannes B. Müller-Reif1,
- Furkan M. Torun1,
- Michael Weigand2,
- Peter Eichhorn2,
- Mathias Bruegel2,
- Maximilian T. Strauss1,
- Lesca M. Holdt2,
- Matthias Mann3 and
- Daniel Teupser2,*
- 1OmicEra Diagnostics GmbH, Planegg, Germany
- 2Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany
- 3NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
- ↵*To whom correspondence should be addressed: Geyer{at}OmicEra.com or Daniel.Teupser{at}med.uni-muenchen.de
Posted February 23, 2021.
High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversion
